Edinburgh, Scotland – 23 November 2011: Roslin Cells Ltd., world leaders in the isolation of new clinical grade pluripotent stem cells, announced today that it has now moved to the new Scottish Centre for Regenerative Medicine at Edinburgh BioQuarter.
Wednesday, November 23, 2011 at 9:00AM UK, July 2011 – Roslin Cells and Pfizer Limited have signed an agreement for Pfizer to evaluate Roslin’s GMP quality Pluripotent Stem Cells (PSC).
Wednesday, July 13, 2011 at 9:00AM Edinburgh, Scotland – 21 June 2011: Roslin Cells Ltd., world leaders in the isolation of new clinical grade undifferentiated stem cells, and Advanced Cell Technology, Inc. (ACT), one of the leading US companies in regenerative medicine, announced that they have entered into a collaboration agreement to establish new clinical grade human embryonic stem cell (hESC) lines using ACTs patented, proprietary “single-cell blastomere” technique.
Tuesday, June 21, 2011 at 9:00AM Edinburgh, Scotland – 06 June 2011: Roslin Cells Ltd., world leaders in the isolation of new clinical grade undifferentiated stem cells, announced today that is has successfully retained certification to ISO 9001, the internationally recognised management system standard which serves as a benchmark for quality management systems.
Monday, June 6, 2011 at 9:00AM Sistemic Ltd and Roslin Cells Ltd.
London, 10th May 2011: Sistemic Ltd and Roslin Cells Ltd today signed a Memorandum of Understanding to promote the development of new technologies for the standardisation of the manufacture of stem cells for their use in cell therapy and drug development screening.
Tuesday, May 10, 2011 at 9:00AM Edinburgh, UK, 13 December 2010 – On November 18 Roslin Cells Ltd. won the Midlothian and East Lothian Chamber of Commerce High Growth Award for 2010. The award, sponsored by the accountancy group Springfords, goes to businesses who demonstrate investment in future development that substantially improves their performance or potential growth.
Monday, December 13, 2010 at 9:00AM Edinburgh, UK, 04 October 2010 – Roslin Cells Ltd., a leading provider of clinical grade pluripotent stem cells, announced today the Roslin Cell Therapy Partner Program. This innovative program will assist researchers in commercial and academic organisations with world leading expertise in the biology of cells of a particular type to translate their research into cell therapies which could be applied in the regenerative medicine field.
Monday, October 4, 2010 at 9:00AM Edinburgh, UK, 05 August 2010 – Roslin Cells Ltd. has entered a worldwide, in kind research collaboration agreement with Lonza, Walkersville, Inc. (US) for the development of customized cell culture media and processes for the production of pluripotent stem cells (PSCs) to advance the field of cell therapy.
Thursday, August 5, 2010 at 9:00AM 
